Dov A. Md Goldstein - Sep 20, 2022 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
GANX
Transactions as of
Sep 20, 2022
Transactions value $
$0
Form type
4
Date filed
9/22/2022, 04:10 PM
Previous filing
Sep 12, 2022
Next filing
Dec 28, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Stock Option (right to buy) Award $0 +10.5K $0.00 10.5K Sep 20, 2022 Common Stock 10.5K $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney